Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

MEDICE

Corporate venture profile

Parent MEDICE Arzneimittel Pütter

MEDICE is the corporate venture arm of MEDICE Arzneimittel Pütter, a pharmaceutical and biotech company. It invests at the Series B stage. Sectors it names: biotech and life sciences.

Every figure links to its source

Snapshot

Investment stage: Series B to Series B
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeries B to Series B
SectorsBiotech and life sciences
GeographyEurope

Sources: S1 HMNC Brain Health: USD 50 million first closing of Series B and strategic partnership with MEDICE (2026).

Graphic 1 of 1

Investment stage: Series B to Series B

Sources: S1 HMNC Brain Health: USD 50 million first closing of Series B and strategic partnership with MEDICE (2026).

Download:Report a correction

Where it invests

Geography

Investment regionsS1

Key facts

FactValueStatusSource
Parent companyMEDICE Arzneimittel PütterSingle sourceS1
Parent industryPharmaceuticals and biotechSingle sourceS1
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1
StagesSeries B (inferred from announced rounds)EstimateS1

History

  1. MEDICE leads USD 50 million first closing of HMNC Brain Health Series B with a licensing allianceS1

Portfolio

Portfolio company named in public sources: HMNC Brain Health.S1

Official pages

Read the firm's own pages for current information.

Sources

  1. S1HMNC Brain Health: USD 50 million first closing of Series B and strategic partnership with MEDICE (2026)Portfolio company

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by MEDICE or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.